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Abstract
Buruli Ulcer (BU) is a necrotizing skin disease caused byMycobacterium ulcerans infection.
BU is characterized by a wide range of clinical forms, including non-ulcerative cutaneous
lesions that can evolve into severe ulcers if left untreated. Nevertheless, spontaneous heal-
ing has been reported to occur, although knowledge on this process is scarce both in natu-
rally infected humans and experimental models of infection. Animal models are useful since
they mimic different spectrums of human BU disease and have the potential to elucidate the
pathogenic/protective pathway(s) involved in disease/healing. In this time-lapsed study, we
characterized the guinea pig, an animal model of resistance toM. ulcerans, focusing on the
macroscopic, microbiological and histological evolution throughout the entire experimental
infectious process. Subcutaneous infection of guinea pigs with a virulent strain ofM. ulcer-
ans led to early localized swelling, which evolved into small well defined ulcers. These mac-
roscopic observations correlated with the presence of necrosis, acute inflammatory infiltrate
and an abundant bacterial load. By the end of the infectious process when ulcerative lesions
healed,M. ulcerans viability decreased and the subcutaneous tissue organization returned
to its normal state after a process of continuous healing characterized by tissue granulation
and reepethelialization. In conclusion, we show that the experimentalM. ulcerans infection
of the guinea pig mimics the process of spontaneous healing described in BU patients, dis-
playing the potential to uncover correlates of protection against BU, which can ultimately
contribute to the development of new prophylactic and therapeutic strategies.
Author Summary
Buruli Ulcer (BU) is a devastating skin disease caused byMycobacterium ulcerans. BU usu-
ally starts off as a non-ulcerative lesion, but if lesions are left untreated they can evolve into
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ulcers or may even affect the bone. Nevertheless, spontaneous healing of active lesions has
been reported in some patients, although little is known about this process. In this study, the
authors performed a time-lapsed study on a resistant animal model ofM. ulcerans infec-
tion–the guinea pig. Subcutaneous infection of the guinea pig led to the development of
ulcerative lesions that eventually healed over the course of infection and, interestingly, this
healing was associated with a decrease inM. ulcerans viability and with an ongoing repara-
tive process of the infected tissue. Given that similar observations have been made in BU
patients that spontaneously resolvedM. ulcerans infection, the guinea pig model has the
potential to disclose the protective immune mechanisms underlying resistance to BU.
Introduction
Buruli Ulcer (BU) is a necrotizing skin disease caused byMycobacterium ulcerans.M. ulcerans
pathogenesis is mediated by mycolactone, a potent polyketide-derived macrolide that triggers
apoptotic cell death [1,2]. Initial pre-ulcerative BU lesions are indolent with no systemic symp-
toms, which often results in a delay in health-care seeking. If lesions are left untreated, they can
evolve into severe extensive ulcers with characteristic undermined edges and a necrotic
sloughed center [3]. In the most extreme cases,M. ulceransmay invade the bone [4,5].
Spontaneous healing of active lesions is thought to be frequent [6–8], although the rate at
which this occurs has not been specifically addressed. Therefore, all forms of BU are subjected
to the standard first-line treatment, consisting of daily administration of streptomycin and
rifampicin for an 8-12-week period [9]. Additional surgical debridement and skin grafting may
also be required in the case of extensive lesions. The healing process of severe lesions, whether
spontaneous or antibiotic-induced, often results in atrophic scarring, contractures, and severe
functional disabilities, ultimately having a negative impact on socioeconomical development
[10]. This is why prevention, early detection and treatment have been a priority for the control
of BU. Therefore, a better knowledge on the nature of protective responses againstM. ulcerans
could improve patient management. In that sense, animal models of infection have been exten-
sively used, not only to characterizeM. ulcerans disease progression [11], but also to dissect
immunological pathways [12–16] and to evaluate the efficiency of antibiotic regimens [17–21]
or vaccine candidates [22–27].
The most common animal model used for the study ofM. ulcerans infection has been the
mouse, in which experimental infection was shown to be progressive, leading to an exponential
increase in bacterial burdens, a continuous destruction of infiltrating cells, expansion of necro-
sis into healthy tissue and ulceration of the epidermis, similar to what is observed in active, pro-
gressive human BU [12,28]. The guinea pig model has also been used for the study ofM.
ulcerans infection [1,11,29–31]; however, definitive experimentation on the nature of disease
progression in this animal model has been limited. Therefore, in this study, we proposed to
perform a detailed characterization of the progression ofM. ulcerans infection in the guinea
pig model, focusing on macroscopic, microbiological and histological evolution.
Results
Spontaneous healing of ulcerative lesions and clearance ofM. ulcerans
in infected guinea pigs
The mouse has been the animal model of choice to characterize progressiveM. ulcerans disease
[11], to dissect immunopathologic pathways [12–16] and to evaluate the efficiency of antibiotic
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regimens [17–21] or vaccine candidates [22–27]. Although less explored, the guinea pig model
has also been used to studyM. ulcerans infection, with published reports focusing mainly on
the evolution of the macroscopic features and on the histopathology of early time points
[11,29–31]. In this study, we decided to explore this overlooked animal model, by performing a
time-lapsed study of the macroscopic, histological, and microbiological evolution ofM. ulcer-
ans infection in the ear or the back of the guinea pig.
Initially, subcutaneous infection withM. ulcerans 98–912 in the ear or back of guinea pigs
led to early focal indurated erythema (Fig 1A, 1B, 1G and 1H), reminiscent of a nodule-like
structure. During the course of infection, these lesions progressed to small ulcers with overlying
scabs (Fig 1B, 1C, 1I and 1J). Between days 18–26, scabs detached revealing a healed and ree-
pithelialized lesion, with occasional scarring (Fig 1D–1F and 1K). An important observation
was that these macroscopic alterations were accompanied by bacterial clearance, regardless the
site of infection (Fig 2A and 2B), the infecting strain (M. ulcerans 98–912—Fig 2B orM. ulcer-
ans 1615—Fig 2C) or the infectious dose (4.5log10 CFU—Fig 2A or 7.4log10 CFU—Fig 2D).
Histological analysis of the healing process inM. ulcerans–infected
tissue of guinea pigs
In line with the macroscopic observations described above, histological analysis of the infected
skin of the guinea pig showed signs of a dynamic infectious process culminating with a tissue
reparation and bacterial clearance (Figs 3 and 4).
During the first week of infection, the underlying dermis was edematous (Figs 3A and 4B)
and focally necrotic (Figs 3A, 3B and 4A–4F), with diffuse infiltration of neutrophils and his-
tiocytes (Fig 4E). Bacteria were mainly concentrated in clumps within the necrotic foci, but
Fig 1. Macroscopic progression ofM. ulcerans infection in the guinea pig model.Guinea pigs were subcutaneously infected in the ear (A-F) or in the
back (G-K) with approximately 4log10 CFU ofM. ulcerans strain 98–912. The macroscopic progression of the lesions at the site of infection was
photographed over the course of experimental infection in the ear: (A) 4days; (B) 8days; (C) 14days; (D) 18days; (E) 26days; (F) 35days; or in the back (G)
8days; (H) 12days; (I) 16days; (J) 21days; (K) 35days. Arrowheads represent the site of subcutaneousM. ulcerans infection. One experiment representative
of three total experiments is shown. Scale: 1cm.
doi:10.1371/journal.pntd.0004265.g001
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could also be found co-localized with phagocytic cells (Fig 4C and 4F). These necrotic areas
expanded progressively during the first week of infection, resulting both in an increase in cells
with apoptotic morphology (Fig 4D) and in an initial epidermal destruction (Fig 4B). However,
Fig 2. Evolution of bacterial viability ofM. ulcerans in the guinea-pig model.Guinea pigs were subcutaneously infected (A) in the ear withM. ulcerans
strain 98–912; (B) in the back withM. ulcerans strain 98–912; (C) in the back withM. ulcerans strain 1615 or (D) in the ear with a high initial infectious dose of
M. ulcerans strain 98–912. At different time points post-infection, infected tissue was harvested and viable bacterial counts were performed. Dashed line
represents the detection limit. Data points represent the mean ± SEM (n = 4–5) for each time point. One experiment representative of three total experiments
is shown. Statistical significance was calculated with One way ANOVA, post-hoc Tukey test. Presented p-values correspond to the comparison of all time
points with the last time point for which the bacterial load is above the dashed line (** p<0.01; ***p<0.001).
doi:10.1371/journal.pntd.0004265.g002
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Fig 3. Histological overview ofM. ulcerans infected skin in the guinea pig model.Guinea pigs were
subcutaneously infected in the ear with 4.5 log10 CFU ofM. ulcerans strain 98–912. Histological sections of
ExperimentalMycobacterium ulcerans Infection in the Guinea Pig
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by day 14 post-infection, signs of active tissue healing were evidenced by a sloughing of the
mycobacteria-rich necrotic tissue (Fig 3C and 3D), accumulation of fibroblasts in the subcuta-
neous tissue (Fig 4G and 4J), intense neovascularization (Fig 4H and 4K) and granulation tis-
sue that gradually replaced the early acute cellular infiltrate (Fig 4G, 4H, 4J and 4K). Analysis
of the infected tissue also indicated an ongoing process of skin reepithelialization, evidenced by
the formation of an eschar composed of degenerating epidermis and collagen over the ulcer-
ated wound, and also by the thickening of the adjacent epidermal layer (Fig 3C and 3D). Inter-
estingly, few bacilli were scattered throughout the granulation tissue, being mainly found
nearby the wound surface (Fig 4I and 4L). By the end of the experimental period of infection
(day 26–35), reepithelialization was complete (Fig 3E and 3F), although fibroplasia (increased
deposition of collagen fibers) (Fig 4M, 4N, 4P and 4Q) and epidermal hyperplasia (elongation
of rete ridges) (Fig 3E and 3F) were still evident. In accordance with the CFU counts shown in
Fig 2, rare or no bacilli could be observed in the infected tissue by day 26 post-infection and
until the end of the experimental period (Fig 4O and 4R).
Discussion
M. ulcerans is a human pathogen, which has recently been shown to naturally infect other
mammals in Australia [32–35]. Regarding experimental models of infection, early studies have
established the capacity ofM. ulcerans to infect a variety of mammals, namely mice and guinea
pigs [11,29,30].
It has been well demonstrated that experimentalM. ulcerans infection in the murine model
mimics the main features of active, progressive BU [36] (S1 Fig). Indeed, infection with virulent
M. ulcerans strains induces a persistent acute inflammatory response throughout infection
[12]; however, mycolactone destroys the recruited inflammatory infiltrates generating necrotic
acellular areas with extracellular bacilli released by the lysis of infected phagocytes [12,28].
These necrotic areas gradually expand, through the progressive invasion of healthy tissues,
eventually resulting in ulceration of the epidermis [12,28].
The guinea pig model, on the other hand, has been occasionally used in BU research,
namely to characterize the pathogenicity ofM. ulcerans and its toxin [1,11,29–31]. It has been
described that following intradermal infection guinea pigs developed initial localized swelling
followed by the appearance of ulcerative lesions. Histologically, these lesions were character-
ized by necrosis, clumps of AFB and diffuse infiltration of polymorphonuclear cells and histio-
cytes [29,30]. Interestingly, these ulcerative lesions ultimately healed, although further analysis
of the healing phase was not explored [29,30].
In the present study, we confirm the previous observations in the guinea pig model and fur-
ther these findings with a time-lapsed histological and microbiological analysis ofM. ulcerans
infected tissues. At early time points, infected guinea pig tissue showed focal necrotic areas har-
bouring intense bacterial loads, compromised epidermal layers, and recruitment of neutrophils
and mononuclear cells to the infectious foci. This acute inflammatory profile was gradually
replaced by granulation tissue and it is during this transition phase that we observe a decrease
inM. ulcerans viability. By the end of the infectious process, we observed complete reepithelia-
lization of the wound surface and scarce/absent bacilli in the tissue. This study contributes to
ears collected at different time points were stained with HE. Magnification of images 4x. At day 4 (A) and day
8 (B), edema (dotted line) and necrosis (full line), associated with a surrounding inflammatory, infiltrate were
the predominant features. By day 8, necrosis expanded throughout the tissue, resulting in epidermal
ulceration (triangles). Day 14 (C) and day 18 (D), were characterized by the presence of an eschar (arrows)
over the wounded surface and epidermal hyperplasia (asterisks). By day 26 (E) and day 35 (F), complete
repethilialization was evident, as well as epidermal hyperplasia and elongation of rete ridges (asterisks).
doi:10.1371/journal.pntd.0004265.g003
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Fig 4. Histological details ofM. ulcerans infected skin in the guinea pig model.Guinea pigs were subcutaneously infected in the ear with 4.5 log10 CFU
ofM. ulcerans strain 98–912. Histological sections of ears collected at different time points were stained with HE (A-B, D-E, G-H, J-K, M-N, P-Q) or ZN (C, F,
I, L, O, R). Magnification of images 60x. At day 4 (A-C) and day 8 (D-F), necrotic foci (n), edema (e), hemorrhage (h), and an acute inflammatory infiltrate
(arrowheads) were the main features of the infected tissue. By day 14 (G-I) and day 18 (J-L), initiation of wound healing was evident by the presence of
granulation tissue, characterized by a fibroblastic population (triangles) and neovascularization (asterisks). At day 26 (M-O) and day 35 (P-R), fibroblasts
ExperimentalMycobacterium ulcerans Infection in the Guinea Pig
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raise relevant questions that should be addressed in future studies, such as whether the immune
response plays a role in the control ofM. ulcerans proliferation; whether lesions are completely
sterilized or ifM. ulcerans remains latent in the tissue; and whether cells from the guinea pig or
the mouse present a differential susceptibility to mycolactone.
Similar observations have been made in BU patients that spontaneously resolvedM. ulcer-
ans infection before developing extensive destructive lesions [6–8]. Connor and Lunn were the
first to propose three histopathological stages in humanM. ulcerans infection: the stage of
necrosis, the organizing stage, and the healing stage [6], all of which were identified in the
guinea pig tissue duringM. ulcerans experimental infection. Additionally, Revill et al. reported
the spontaneous healing of small BU lesions in 29% of the clinically diagnosed patients that
were receiving placebo during a randomized study of clofazamine therapy [7]. More recently,
Gordon et al. reported a case in which a patient became IS2404 PCR, ZN and culture negative,
one month after laboratory confirmation of initial BU diagnosis [8]. This decrease in bacterial
viability also coincided with the presence of mixed inflammatory cell infiltration and granula-
tion tissue [8]. Taking into consideration these similarities, studies on the guinea pig model
have the potential to disclose the protective mechanisms underlying resistance to BU in
humans.
More recently, other animal models ofM. ulcerans infection have been proposed to better
understand the early host-pathogen interactions and the pathogenesis of BU, namely the mon-
key [37] and pig models [38]. The cynomolgus monkey developed papules that progressed to
ulcers with undermined borders afterM. ulcerans infection. Histological analysis of biopsies
from ulcer edges showed necrosis, robust inflammatory infiltrates, granulomatous-like
responses, mild edema, and extracellular acid-fast bacilli [37]. Similarly to the guinea pig, ulcers
eventually healed spontaneously with no signs of systemic infection [37]. On the other hand, in
the porcine model, infection withM. ulcerans leads to the development of nodular lesions that
subsequently progress to ulcers [38], similar to what we describe here for the guinea pig. How-
ever, in the porcine model, only low doses ofM. ulcerans infection lead to spontaneous healing
of ulcerative lesions, while high doses resulted in progressive infection during the experimental
period [38]. Among these animal models of resistance, the guinea pig presents several advan-
tages, namely smaller size, lower cost and maintenance, making it a more accessible model to
study mechanisms of protection againstM. ulcerans infection.
In conclusion, both the mouse and the guinea pig are useful experimental models since they
mimic different spectrums of humanM. ulcerans disease, therefore contributing to elucidate
the pathogenic/protective pathway(s) involved in disease-progression/healing, respectively.
Here we show that further studies on the cellular and molecular components of the protective
response in the guinea pig model have the potential to uncover correlates of protection against
BU.
Methods
Bacteria
M. ulcerans 98–912 (ITM collection, Antwerp, Belgium) is a mycolactone D producing strain
isolated in China from an ulcerative lesion [39].M. ulcerans 1615 is a mycolactones A/B pro-
ducing strain isolated in Malaysia from an ulcerative case. The isolates were grown on Mid-
dlebrook 7H9 medium (Becton, Dickinson and Company) with agar at 32°C for approximately
(traingles) and newly formed vessel (asterisks) were still present and there was an increased deposition of elongated pink collagen fibers. The bacterial load
(C, F, I, L, O, R) decreased over the course of infection.
doi:10.1371/journal.pntd.0004265.g004
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6–8 weeks. For the preparation of the inoculum,M. ulcerans was recovered, diluted in phos-
phate-buffered saline (PBS) and vortexed using glass beads.
M. ulcerans experimental infection
Female Hartley guinea-pigs and Balb/c mice were obtained from Charles River (Barcelona,
Spain) and were housed in specific pathogen free conditions with food and water ad libitum.
Before experimental infection, guinea pigs were anesthetized with 40mg/kg of ketamine and
0.5mg/kg of medetomidine via intraperitoneal (i.p.) injection. Guinea pigs were infected subcu-
taneously (s.c.) in the dorsal area (after the removal of the fur) or the ear with 100μl ofM. ulcer-
ans strain 98–912 or 1615. After infection, anesthesia was reverted with 1mg/kg of atipamezol
via i.p. injection. At different time points post-infection, guinea pigs were sacrificed by i.p.
injection of 150mg/kg of pentobarbital. In parallel, mice were anesthetized with 75mg/kg keta-
mine and 1mg/kg medetomidine administered via i.p. and were then s.c. infected in the ear
with 10μl ofM. ulcerans inoculum. Anesthesia was reverted with 1mg/kg of atipamezol via i.p.
injection. Mice were sacrificed by asphyxiation with increasing concentrations of CO2. For
each experiment, the susceptible mouse model was used to confirm of the virulence of theM.
ulcerans strain.
Bacterial load determination
Infected tissue was excised, homogenized and diluted in PBS. Suspensions were decontami-
nated with hydrochloric acid (HCl) 1M containing 0,001% phenol red solution for 15min at
room temperature, followed by neutralization with sodium hydroxide (NaOH) 1M. Suspen-
sions were centrifuged and the pellet resuspended in PBS. Serial dilutions of the suspension
were plated on nutrient 7H9 + 1,5% agar. Bacterial colony formation was counted after 6–8
weeks of incubation at 32°C. Following ASTM guidelines, the reported value for the limit of
detection for microbiological purposes should be “< the dilution value” if no colonies are
recovered; therefore the limit of detection for our experiments is 1log10CFU/ml. All countable
colonies, even those below the countable range, were counted and reported as an estimated
count.
Histological studies
Infected tissue was fixed in buffered formalin and embedded in paraffin. Light-microscopy
studies were performed on tissue sections stained with hematoxylin and eosin (HE) or Ziehl-
Neelsen (ZN). Images were obtained with an Olympus BX61 microscope.
Statistical analysis
Differences between the means of experimental groups were analyzed with the One Way
Anova-test post-hoc Tukey. Differences with a p-value of0.05 were considered significant.
Ethics statement
This study was approved by the Portuguese National Authority for animal experimentation
Direcção Geral de Alimentação e Veterinária. Animals were kept and handled in accordance
with the guidelines for the care and handling of laboratory animals in the European Union
Directive 86/609/EEC.
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Supporting Information
S1 Fig. Macroscopic progression ofM. ulcerans infection in the mouse ear model. Balb/c
mice were subcutaneously infected in the ear with approximately 6log10 CFU ofM. ulcerans
strain 98–912. The macroscopic progression of the lesions at the site of infection were photo-
graphed over the course of experimental infection: (A) 3 days; (B) 14 days; (C) 27 days; (D) 55
days; (E) 70 days; (F) 105 days. One experiment representative of two total experiments is
shown. Scale: 1cm.
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